Showing results (1721-1730 of 5,493) with videos related to
Sort By:
Pageof 550
Pharmacotherapy|April 8, 2020
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019Ashley Barlow, Kaitlin M Landolf, Brooke Barlow, et al.Pharmacotherapy|June 17, 2020
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID-19Sarah C J Jorgensen, Christopher L Y Tse, Lisa Burry, et al.Pharmacotherapy|August 25, 2025
Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to WarfarinOluwadolapo D Lawal, Herbert D Aronow, Fisayomi Shobayo, et al.Pharmacotherapy|August 14, 2016
Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall SurvivalJanna Afanasjeva, Rita L Hui, Michele M Spence, et al.Pharmacotherapy|July 1, 1984
Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailabilityG Milavetz, M Weinberger, L VaughanPharmacotherapy|July 1, 1981
Trimethoprim: mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indicationsR Gleckman, N Blagg, D W JoubertPharmacotherapy|July 1, 1981
Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infectionsF P Tally, C E SullivanPharmacotherapy|July 1, 1981
Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosidesG C Yee, W E EvansPharmacotherapy|September 5, 2025
Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab: Urinary Retention With IV LecanemabAmber N Navarra, Laura A Wang, Heba Al-Sahlani, et al.Pharmacotherapy|May 27, 2015
Medication management of cardiac allograft vasculopathy after heart transplantationIan B Hollis, Brent N Reed, Michael P MoranvillePageof 550